From nanotags to precision biomedicine: SERS-driven progress and innovation in tumor biomarker profiling, dynamic bioimaging, AI-enhanced diagnostics and therapy

Q: What does this research mean for the field?

Surface-Enhanced Raman Scattering (SERS) technology, particularly when integrated with artificial intelligence and multimodal approaches, offers significant potential for advancing precision biomedicine in tumor biomarker profiling, bioimaging, diagnostics, and therapy. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

Xuelin Chen; Tenglong Liu; Weiyuan Chen; Zhexuan Lin; Qiaoxin Zhang; Binbin Zhou; Xia Zhou

doi:10.7150/thno.126530

January 1, 2026TheranosticsOpen Access

From nanotags to precision biomedicine: SERS-driven progress and innovation in tumor biomarker profiling, dynamic bioimaging, AI-enhanced diagnostics and therapy

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to investigate the advancements of SERS technology in tumor diagnostics and treatment.
Evaluated AI-assisted spectral analysis for tumor diagnostics.
Reviewed multimodal integration and standardized detection protocols.
Discussed large-scale clinical applications of SERS technology.
SERS technology enhances tumor biomarker profiling.
AI-assisted diagnostics show improved precision in bioimaging.
Integration of SERS in clinical settings suggests potential for point-of-care applications.

Implication

Explores SERS technology for tumor biomarker profiling and AI-enhanced diagnostics, suggesting advancements in precision biomedicine.

Abstract

diagnosis; (2) bioimaging; (3) tumor treatment; (4) Artificial intelligence-assisted tumor diagnosis and treatment. Finally, we made the forward look for SERS technology in biomedicine, such as multimodal integration, standardized detection protocols, AI-assisted spectral analysis for point-of-care diagnostics, and large-scale clinical applications.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2026) studied this question.

synapsesocial.com/papers/6a64f169f883a62dea1c4332 https://doi.org/10.7150/thno.126530

View Full Paper

Ask AI

Bookmark

Share

From nanotags to precision biomedicine: SERS-driven progress and innovation in tumor biomarker profiling, dynamic bioimaging, AI-enhanced diagnostics and therapy

Key Points

Implication

Abstract

Discussion

Cite This Study

From nanotags to precision biomedicine: SERS-driven progress and innovation in tumor biomarker profiling, dynamic bioimaging, AI-enhanced diagnostics and therapy

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading